Bone marrow‐derived mesenchymal stem cells inhibit NK cell function via Tim‐3/galectin‐9 in multiple myeloma patients
Clinical and Translational Medicine · 2023
DOI: 10.1002/ctm2.1224 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Translational Medicine, 2023. Verfasst von Zhao-Yun Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Tianjin Medical University General Hospital, Heping District, Tianjin, People's Republic of China. Hauptthemen laut MEDLINE: Multiple Myeloma, Mesenchymal Stem Cells. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China Youth Project, Tianjin Municipal Natural Science Foundation, Tianjin Education Commission Research Project.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Tianjin Medical University General Hospital, Heping District, Tianjin, People's Republic of China.
ORCID-Profile: Nan-Hao Meng, Yue Jia, Rong Fu
Förderung
- National Natural Science Foundation of China Youth Project
- Tianjin Municipal Natural Science Foundation
- Tianjin Education Commission Research Project
- Tianjin Science and Technology Planning Project
- Tianjin Municipal Health Commission Youth Project
- Medjaden Academy & Research Foundation for Young Scientists
- Tianjin Key Medical Discipline(Specialty) Construction Project
Zitieren
APA
Liu, Z. Y., Meng, N. H., Cao, P. P., Jia, Y., Wang, H., Zhang, Y. H., Liu, H., & Fu, R. (2023). Bone marrow‐derived mesenchymal stem cells inhibit NK cell function via Tim‐3/galectin‐9 in multiple myeloma patients. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1224
Vancouver
Liu ZY, Meng NH, Cao PP, Jia Y, Wang H, Zhang YH, et al. Bone marrow‐derived mesenchymal stem cells inhibit NK cell function via Tim‐3/galectin‐9 in multiple myeloma patients. Clinical and Translational Medicine. 2023. doi:10.1002/ctm2.1224
BibTeX
@article{Liu2023,
author = {Liu, Zhao-Yun and Meng, Nan-Hao and Cao, Pan-Pan and Jia, Yue and Wang, Hao and Zhang, Yun-He and Liu, Hui and Fu, Rong},
title = {Bone marrow‐derived mesenchymal stem cells inhibit NK cell function via Tim‐3/galectin‐9 in multiple myeloma patients},
journal = {Clinical and Translational Medicine},
year = {2023},
doi = {10.1002/ctm2.1224}
}
EUVIMED